| Literature DB >> 30219052 |
Minsuk Oh1, Sue Kim2, Ki-Yong An3, Jihee Min4,5, Hyuk In Yang4,5, Junga Lee6, Mi Kyung Lee4,5, Dong-Il Kim7, Hye-Sun Lee8, Ji-Won Lee9, Justin Y Jeon10,11.
Abstract
BACKGROUND: It has been recognized that alternate day calorie restriction (ADCR) or exercise has positive effects on cardio-metabolic risk factors. It is unclear whether the combined effect of ADCR and exercise (aerobic + resistance training) influences risk. We investigated effects of an 8-week ADCR and exercise program (aerobic + resistance training) on cardio-metabolic risk factors in overweight and obese adults.Entities:
Keywords: Alternate day calorie restriction; Body weight; Exercise; Insulin resistance; Obesity
Mesh:
Substances:
Year: 2018 PMID: 30219052 PMCID: PMC6139127 DOI: 10.1186/s12889-018-6009-1
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Effect of intervention on anthropometric and body measurements (ITT)
| Variables | Group | Baseline | Week 8 | Change | |
|---|---|---|---|---|---|
| Body weight (kg) | E-ADCR ( | 74.0 ± 13.7 | 70.7 ± 14.2a | − 3.3 ± 2.4 | 0.064 |
| ADCR ( | 74.1 ± 11.5 | 71.7 ± 11.0b | − 2.4 ± 3.1 | ||
| Exercise ( | 83.2 ± 16.7 | 81.8 ± 16.3 | − 1.4 ± 2.1 | ||
| Control ( | 70.8 ± 13.6 | 70.2 ± 13.8 | − 0.6 ± 1.3 | ||
| BMI (kg/m2) | E-ADCR ( | 27.5 ± 2.6 | 26.3 ± 3.1a | − 1.3 ± 1.0c | 0.036 |
| ADCR ( | 27.6 ± 2.8 | 26.7 ± 2.5b | − 0.9 ± 1.3 | ||
| Exercise ( | 28.3 ± 4.1 | 27.9 ± 4.2b | − 0.5 ± 0.6 | ||
| Control ( | 26.3 ± 3.1 | 26.2 ± 3.0 | −0.1 ± 0.5 | ||
| WC (cm) | E-ADCR ( | 90.5 ± 6.6 | 86.4 ± 8.5a | −4.1 ± 3.9 | 0.267 |
| ADCR ( | 91.6 ± 7.9 | 89.4 ± 8.3b | − 2.2 ± 3.6 | ||
| Exercise ( | 95.5 ± 11.9 | 92.6 ± 12.0b | − 2.9 ± 3.8 | ||
| Control ( | 88.5 ± 7.6 | 87.0 ± 8.9 | − 1.5 ± 1.9 | ||
| Muscle mass (kg) | E-ADCR ( | 27.2 ± 7.4 | 26.8 ± 7.5b | − 0.4 ± 0.5 | 0.696 |
| ADCR ( | 26.6 ± 4.8 | 26.1 ± 4.6 | − 0.5 ± 0.9 | ||
| Exercise ( | 32.3 ± 7.2 | 32.1 ± 6.8 | − 0.1 ± 0.9 | ||
| Control (n = 10) | 26.5 ± 5.8 | 26.3 ± 6.1 | − 0.2 ± 0.7 | ||
| Fat mass (kg) | E-ADCR ( | 25.0 ± 4.6 | 22.3 ± 5.4a | − 2.7 ± 2.0c | 0.036 |
| ADCR (n = 13) | 26.0 ± 5.5 | 24.3 ± 6.4 | − 1.6 ± 2.3 | ||
| Exercise ( | 25.8 ± 7.2 | 24.5 ± 7.1 | − 1.2 ± 1.9 | ||
| Control ( | 22.9 ± 5.5 | 22.6 ± 5.7 | −0.3 ± 1.3 | ||
| Percent body fat (%) | E-ADCR ( | 34.2 ± 6.1 | 31.8 ± 6.8a | − 2.5 ± 2.2c | 0.071 |
| ADCR ( | 34.9 ± 4.6 | 33.6 ± 6.6b | −1.26 ± 2.4 | ||
| Exercise ( | 31.0 ± 5.0 | 29.9 ± 4.4 | − 1.1 ± 1.8 | ||
| Control ( | 32.2 ± 4.4 | 32.2 ± 5.0 | −0.1 ± 1.5 | ||
| SBP (mmHg) | E-ADCR ( | 120.8 ± 11.9 | 117.5 ± 10.4 | − 3.3 ± 8.3 | 0.389 |
| ADCR ( | 119.6 ± 16.7 | 117.9 ± 17.1 | −1.8 ± 5.8 | ||
| Exercise ( | 125.3 ± 16.8 | 119.5 ± 10.3 | −5.8 ± 8.8 | ||
| Control (n = 10) | 117.3 ± 14.4 | 117.3 ± 14.6 | 0.0 ± 8.1 | ||
| DBP (mmHg) | E-ADCR (n = 12) | 80.3 ± 11.3 | 77.9 ± 7.9 | −2.3 ± 4.6 | 0.337 |
| ADCR (n = 13) | 78.1 ± 14.0 | 77.0 ± 12.8 | −1.4 ± 8.6 | ||
| Exercise (n = 10) | 83.5 ± 8.7 | 79.8 ± 10.5 | −3.7 ± 8.3 | ||
| Control (n = 10) | 78.1 ± 10.2 | 79.9 ± 10.8 | 1.8 ± 5.0 |
Data are presented as mean ± SD
E-ADCR Exercise plus alternate day calorie restriction, ADCR Alternate day calorie restriction, BMI Body mass index, WC Waist circumference, SBP Systolic blood pressure, DBP Diastolic blood pressure, HR Heart rate, HOMA-IR Homeostasis model assessment-insulin resistance, TG Triglycerides, TC Total cholesterol, HDL-C High-density lipoprotein cholesterol
aSignificantly different between baseline and week 8, p < 0.01
bSignificantly different between baseline and week 8, p < 0.05
cSignificantly different with the control group, p < 0.05; p values were obtained by One-way ANOVA with Tukey post-hoc analysis
Effect of intervention on blood lipids and insulin resistance (ITT)
| Variables | Group | Baseline | Week 8 | Change | |
|---|---|---|---|---|---|
| Insulin (μIU/ml) | E-ADCR (n = 12) | 9.4 ± 3.6 | 6.5 ± 3.0b | − 2.9 ± 4.1 | 0.205 |
| ADCR (n = 13) | 9.3 ± 4.1 | 11.8 ± 12.9 | 2.6 ± 11.5 | ||
| Exercise (n = 10) | 7.5 ± 3.6 | 7.6 ± 3.5 | 0.1 ± 3.5 | ||
| Control (n = 10) | 8.5 ± 6.2 | 11.0 ± 7.7 | 2.6 ± 4.0 | ||
| Glucose (mg/dl) | E-ADCR (n = 12) | 98.0 ± 17.0 | 87.08 ± 12.70b | −10.9 ± 16.9 | 0.110 |
| ADCR (n = 13) | 90.0 ± 9.5 | 87.0 ± 8.1 | −3.0 ± 9.4 | ||
| Exercise (n = 10) | 93.0 ± 8.0 | 92.3 ± 7.2 | −0.7 ± 8.3 | ||
| Control (n = 10) | 87.0 ± 5.4 | 86.0 ± 5.7 | − 1.0 ± 5.0 | ||
| HOMA-IR | E-ADCR (n = 12) | 2.4 ± 1.4 | 1.4 ± 0.8b | − 0.9 ± 1.3 | 0.132 |
| ADCR (n = 13) | 2.1 ± 1.0 | 2.7 ± 3.3 | 0.6 ± 2.8 | ||
| Exercise (n = 10) | 1.7 ± 0.9 | 1.8 ± 0.9 | 0.0 ± 0.8 | ||
| Control (n = 10) | 1.8 ± 1.4 | 2.4 ± 1.7 | 0.5 ± 0.9 | ||
| TG (mg/dl) | E-ADCR (n = 12) | 133.4 ± 47.1 | 89.7 ± 33.7a | − 43.8 ± 41.9c, d | 0.004 |
| ADCR (n = 13) | 108.8 ± 48.7 | 120.8 ± 80.6 | 12.0 ± 56.2 | ||
| Exercise (n = 10) | 142.7 ± 78.3 | 106.9 ± 42.7 | − 35.8 ± 55.8 | ||
| Control (n = 10) | 109.5 ± 86.8 | 130.7 ± 86.8 | 21.2 ± 31.0 | ||
| TC (mg/dl) | E-ADCR (n = 12) | 182.8 ± 26.0 | 197.1 ± 28.6 | 14.3 ± 22.9 | 0.475 |
| ADCR (n = 13) | 189.9 ± 23.91 | 193.9 ± 21.6 | 4.1 ± 19.6 | ||
| Exercise (n = 10) | 177.8 ± 33.4 | 191.9 ± 36.4 | 14.1 ± 25.3 | ||
| Control (n = 10) | 178.5 ± 38.0 | 194.8 ± 37.4a | 16.3 ± 13.6 | ||
| HDL-C (mg/dl) | E-ADCR (n = 12) | 48.0 ± 10.4 | 53.3 ± 10.5b | 5.3 ± 8.1 | 0.622 |
| ADCR (n = 13) | 58.5 ± 15.0 | 61.1 ± 15.4 | 2.6 ± 8.3 | ||
| Exercise (n = 10) | 44.8 ± 10.0 | 51.5 ± 8.6b | 6.7 ± 8.5 | ||
| Control (n = 10) | 54.6 ± 11.8 | 59.4 ± 12.4b | 4.9 ± 4.7 |
Data are presented as mean ± SD
E-ADCR Exercise plus alternate day calorie restriction, ADCR Alternate day calorie restriction, BMI Body mass index, WC Waist circumference, SBP Systolic blood pressure, DBP Diastolic blood pressure, HR Heart rate, HOMA-IR Homeostasis model assessment-insulin resistance, TG Triglycerides, TC Total cholesterol, HDL-C High-density lipoprotein cholesterol
aSignificantly different between baseline and week 8, p < 0.01
bSignificantly different between baseline and week 8, p < 0.05
cSignificantly different with the control group, p < 0.05
dSignificantly different with the ADCR group, p < 0.05; p values were obtained by One-way ANOVA with Tukey post-hoc analysis
Fig. 1CONSORT Diagram (Study flow). Abbreviations, E-ADCR, Exercise plus alternate day calorie restriction, ADCR, Alternate day calorie restriction, BMI, Body mass index
Baseline characteristics of the participants
| Variables | E-ADCR | ADCR | Exercise | Control | |
|---|---|---|---|---|---|
| n | 12 | 13 | 10 | 10 | |
| Sex (F, M) | 7, 5 | 10, 3 | 3, 7 | 6, 4 | 0.170 |
| Age (years) | 37.3 ± 7.3 | 32.9 ± 7.3 | 35.7 ± 7.9 | 40.6 ± 10.0 | 0.168 |
| Height (cm) | 163.2 ± 9.2 | 163.5 ± 7.1 | 170.8 ± 7.7 | 163.3 ± 6.9 | 0.086 |
| Body weight (kg) | 74.0 ± 13.7 | 74.1 ± 11.5 | 83.2 ± 16.7 | 70.8 ± 13.6 | 0.227 |
| BMI (kg/m2) | 27.5 ± 2.6 | 27.6 ± 2.8 | 28.3 ± 4.1 | 26.3 ± 3.0 | 0.548 |
| Muscle mass (kg) | 27.2 ± 7.4 | 26.6 ± 4.8 | 32.3 ± 7.2 | 26.5 ± 5.8 | 0.136 |
| Fat mass (kg) | 25.0 ± 4.6 | 25.9 ± 5.5 | 25.8 ± 7.2 | 22.9 ± 5.5 | 0.601 |
| Percent body fat (%) | 34.2 ± 6.1 | 34.9 ± 4.6 | 31.0 ± 5.0 | 32.2 ± 4.4 | 0.258 |
| WC (cm) | 90.5 ± 6.6 | 91.6 ± 7.9 | 95.5 ± 11.9 | 88.5 ± 7.5 | 0.328 |
| SBP (mmHg) | 120.8 ± 11.9 | 119.6 ± 16.7 | 125.3 ± 16.8 | 117.3 ± 14.4 | 0.683 |
| DBP (mmHg) | 80.3 ± 11.3 | 78.1 ± 14.0 | 83.5 ± 8.7 | 78.1 ± 10.2 | 0.668 |
| HR (bpm) | 78.4 ± 10.8 | 78.2 ± 9.4 | 74.2 ± 11.2 | 72.5 ± 12.6 | 0.511 |
| Insulin (uIU/ml) | 9.4 ± 3.5 | 9.3 ± 4.1 | 7.5 ± 3.6 | 8.5 ± 6.2 | 0.741 |
| Glucose (mg/dl) | 98.0 ± 17.0 | 90.0 ± 9.5 | 93.0 ± 8.0 | 87.0 ± 5.4 | 0.131 |
| HOMA-IR | 2.4 ± 1.4 | 2.1 ± 1.0 | 1.7 ± 0.9 | 1.8 ± 1.4 | 0.595 |
| TG (mg/dl) | 133.4 ± 47.1 | 108.8 ± 48.7 | 142.7 ± 78.3 | 109.5 ± 86.8 | 0.543 |
| TC (mg/dl) | 182.8 ± 26.0 | 189.8 ± 23.9 | 177.8 ± 33.4 | 178.5 ± 38.0 | 0.757 |
| HDL-C (mg/dl) | 48.0 ± 10.4 | 58.5 ± 15.0 | 44.8 ± 9.9 | 54.6 ± 11.8 | 0.041 |
Data are presented as mean ± SD
E-ADCR Exercise plus alternate day calorie restriction, ADCR Alternate day calorie restriction, BMI Body mass index, WC Waist circumference, SBP Systolic blood pressure, DBP Diastolic blood pressure, HR Heart rate, HOMA-IR Homeostasis model assessment-insulin resistance, TG Triglycerides, TC Total cholesterol, HDL-C High-density lipoprotein cholesterol